University of Dublin Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02428322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

University of Dublin, Trinity College and St Patrick's Mental Health Services | University of Dundee, Nethergate, Dundee DD1 4HN, Scotland, UK

Active Ingredients

Drugs in Phase 3 Trials (3)

benralizumab (fasenra) (1 trial)

ketamine (ketalar) (1 trial)

midazolam (versed) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4